Managing the Unmanageable: Meeting the Challenge of Appropriate Safety Report Distribution

May 17, 2017

As clinical trials become more complex and increasingly global, the problem of over-distributing expedited safety reports to investigative sites has reached the point that demands a solution. The excessive volume of safety reports can cause investigators to miss important reports lost in the noise of non-significant event reports, and sometimes cause them to reconsider participating in future studies. How can we be sure that investigative sites only receive the reports they truly need to review?

Read this whitepaper to learn about the various methods of distributing safety reports, and what solutions sponsors and CROs should look for to resolve this growing problem.
 

Previous Video
Optimizing Global Safety Reporting in Clinical Trials
Optimizing Global Safety Reporting in Clinical Trials

Learn how a large, global pharmaceutical company saved millions of dollars by optimizing their safety repor...

No More Flipbooks